My watch list
my.chemeurope.com  
Login  

Arginine vasopressin receptor 1B




Arginine vasopressin receptor 1B
Identifiers
Symbol(s) AVPR1B; AVPR3
External IDs OMIM: 600264 MGI: 1347010 Homologene: 22678
Orthologs
Human Mouse
Entrez 553 26361
Ensembl ENSG00000198049 ENSMUSG00000026432
Uniprot P47901 Q9JLP2
Refseq NM_000707 (mRNA)
NP_000698 (protein)
NM_011924 (mRNA)
NP_036054 (protein)
Location Chr 1: 204.39 - 204.4 Mb Chr 1: 133.43 - 133.44 Mb
Pubmed search [1] [2]

Arginine vasopressin receptor 1B (AVPR1B, vasopressin 3 receptor) is a protein that acts as receptor for arginine vasopressin. AVPR1B belongs to the subfamily of G-protein coupled receptors. Its activity is mediated by G proteins which stimulate a phosphatidylinositol-calcium second messenger system.

Additional recommended knowledge

Contents

Tissue distribution

AVPR1B was initially described as a novel vasopressin receptor located in the anterior pituitary, where it stimulates ACTH release.[1] Subsequent studies have shown its presence in the brain as well.[2][3]

Clinical significance

Behavioral

Inactivation of the Avpr1b in mice (knockout) produces mice with greatly reduced aggression and a reduced ability to recognize recently investigated mice.[4] Interestingly, defensive behavior and predatory behaviors appear to normal in these knockout mice.[5] There is evidence that social motivation or awareness is reduced in these mice.[6] The AVPR1B antagonist, SSR149415, has been shown to have anti-aggressive actions in hamsters[7] and anti-depressant- and anxiety (anxiolytic)-like behaviors in rats.[8] A single nucleotide polymorphism (SNP) has been associated with susceptiblility to depression in man.[9]

Metabolic

Various stress-induced elevations of ACTH are blunted in the Avpr1b knockout mouse.[10]

Oncology

AVPR1B is expressed at high levels in ACTH-secreting pituitary adenomas as well as in bronchial carcinoids[11] responsible for the ectopic ACTH syndrome.[12]

Ligands

SSR149415[13] and D-[Leu4-Lys8]-vasopressin[14] are a specific antagonist and agonist for the vasopressin 1b receptor, respectively.

References

  1. ^ Antoni FA, Holmes MC, Makara GB, Kárteszi M, László FA (1984). "Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor". Peptides 5 (3): 519–22. doi:10.1016/0196-9781(84)90080-9. PMID 6089144.
  2. ^ Hernando F, Schoots O, Lolait SJ, Burbach JP (2001). "Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin". Endocrinology 142 (4): 1659–68. doi:10.1210/en.142.4.1659. PMID 11250948.
  3. ^ Young WS, Li J, Wersinger SR, Palkovits M (2006). "The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy". Neuroscience 143 (4): 1031–9. doi:10.1016/j.neuroscience.2006.08.040. PMID 17027167.
  4. ^ Wersinger SR, Ginns EI, O'Carroll AM, Lolait SJ, Young WS (2002). "Vasopressin V1b receptor knockout reduces aggressive behavior in male mice". Mol. Psychiatry 7 (9): 975–84. doi:10.1038/sj.mp.4001195. PMID 12399951.
  5. ^ Wersinger SR, Caldwell HK, Christiansen M, Young WS (2007). "Disruption of the vasopressin 1b receptor gene impairs the attack component of aggressive behavior in mice". Genes Brain Behav. 6 (7): 653–60. doi:10.1111/j.1601-183X.2006.00294.x. PMID 17284170.
  6. ^ Wersinger SR, Kelliher KR, Zufall F, Lolait SJ, O'Carroll AM, Young WS (2004). "Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task". Hormones and Behavior 46 (5): 638–45. doi:10.1016/j.yhbeh.2004.07.004. PMID 15555506.
  7. ^ Blanchard RJ, Griebel G, Farrokhi C, Markham C, Yang M, Blanchard DC (2005). "AVP V1b selective antagonist SSR149415 blocks aggressive behaviors in hamsters". Pharmacol. Biochem. Behav. 80 (1): 189–94. doi:10.1016/j.pbb.2004.10.024. PMID 15652395.
  8. ^ Serradeil-Le Gal C, Wagnon J, Tonnerre B, Roux R, Garcia G, Griebel G, Aulombard A (2005). "An overview of SSR149415, a selective nonpeptide vasopressin V1b receptor antagonist for the treatment of stress-related disorders". CNS Drug Reviews 11 (1): 53–68. doi:10.1111/j.1527-3458.2005.tb00035.x. PMID 15867952.
  9. ^ van West D, Del-Favero J, Aulchenko Y, Oswald P, Souery D, Forsgren T, Sluijs S, Bel-Kacem S, Adolfsson R, Mendlewicz J, Van Duijn C, Deboutte D, Van Broeckhoven C, Claes S (2004). "A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression". Mol. Psychiatry 9 (3): 287–92. doi:10.1038/sj.mp.4001420. PMID 15094789.
  10. ^ Lolait SJ, Stewart LQ, Jessop DS, Young WS, O'Carroll AM (2007). "The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors". Endocrinology 148 (2): 849–56. doi:10.1210/en.2006-1309. PMID 17122081.
  11. ^ Arlt W, Dahia PL, Callies F, Nordmeyer JP, Allolio B, Grossman AB, Reincke M (1997). "Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in vivo and in vitro". Clin. Endocrinol. (Oxf) 47 (5): 623–7. doi:10.1046/j.1365-2265.1997.3091129.x. PMID 9425403.
  12. ^ de Keyzer Y, Lenne F, Auzan C, Jégou S, René P, Vaudry H, Kuhn JM, Luton JP, Clauser E, Bertagna X (1996). "The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome". J. Clin. Invest. 97 (5): 1311–8. PMID 8636444.
  13. ^ Serradeil-Le Gal C, Wagnon J, Simiand J, Griebel G, Lacour C, Guillon G, Barberis C, Brossard G, Soubrié P, Nisato D, Pascal M, Pruss R, Scatton B, Maffrand JP, Le Fur G (2002). "Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist". J. Pharmacol. Exp. Ther. 300 (3): 1122–30. doi:10.1124/jpet.300.3.1122. PMID 11861823.
  14. ^ Pena A, Murat B, Trueba M, Ventura MA, Bertrand G, Cheng LL, Stoev S, Szeto HH, Wo N, Brossard G, Serradeil-Le Gal C, Manning M, Guillon G (2007). "Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors". Endocrinology 148 (9): 4136–46. doi:10.1210/en.2006-1633. PMID 17495006.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Arginine_vasopressin_receptor_1B". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE